ASO Visual Abstract: Serum CEA as Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment-A TAPS Consortium Study.

Deesje DoppenbergThomas F StoopSusan van DierenMatthew H G KatzQuisette P JanssenNaaz NasarLaura R PrakashRutger T TheijseChing-Wei D TzengAlice C WeiAmer H ZureikatBas Groot KoerkampMarc G H Besselinknull null

Published in: Annals of surgical oncology (2024)

Keyphrases

replacement therapy